Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza

Byoung Shik Shim, Young Ki Choi, Cheol Heui Yun, Eu Gene Lee, Yoon Seong Jeon, Sung Moo Park, In Su Cheon, Dong Hyun Joo, Chung Hwan Cho, Min Suk Song, Sang Uk Seo, Young Ho Byun, Hae Jung Park, Haryoung Poo, Baik Lin Seong, Jae Ouk Kim, Huan Huu Nguyen, Konrad Stadler, Dong Wook Kim, Kee Jong HongCecil Czerkinsky, Man Ki Song

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background: The ectodomain of matrix protein 2 (M2e) of influenza A virus is a rationale target antigen candidate for the development of a universal vaccine against influenza as M2e undergoes little sequence variation amongst human influenza A strains. Vaccine-induced M2e-specific antibodies (Abs) have been shown to display significant cross-protective activity in animal models. M2e-based vaccine constructs have been shown to be more protective when administered by the intranasal (i.n.) route than after parenteral injection. However, i.n. administration of vaccines poses rare but serious safety issues associated with retrograde passage of inhaled antigens and adjuvants through the olfactory epithelium. In this study, we examined whether the sublingual (s.l.) route could serve as a safe and effective alternative mucosal delivery route for administering a prototype M2e-based vaccine. The mechanism whereby s.l. immunization with M2e vaccine candidate induces broad protection against infection with different influenza virus subtypes was explored. Methods and Results: A recombinant M2 protein with three tandem copies of the M2e (3M2eC) was expressed in Escherichia coli. Parenteral immunizations of mice with 3M2eC induced high levels of M2e-specific serum Abs but failed to provide complete protection against lethal challenge with influenza virus. In contrast, s.l. immunization with 3M2eC was superior for inducing protection in mice. In the latter animals, protection was associated with specific Ab responses in the lungs. Conclusions: The results demonstrate that s.l. immunization with 3M2eC vaccine induced airway mucosal immune responses along with broad cross-protective immunity to influenza. These findings may contribute to the understanding of the M2-based vaccine approach to control epidemic and pandemic influenza infections.

Original languageEnglish
Article numbere27953
JournalPloS one
Volume6
Issue number11
DOIs
Publication statusPublished - 2011 Nov 30

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Shim, B. S., Choi, Y. K., Yun, C. H., Lee, E. G., Jeon, Y. S., Park, S. M., Cheon, I. S., Joo, D. H., Cho, C. H., Song, M. S., Seo, S. U., Byun, Y. H., Park, H. J., Poo, H., Seong, B. L., Kim, J. O., Nguyen, H. H., Stadler, K., Kim, D. W., ... Song, M. K. (2011). Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza. PloS one, 6(11), [e27953]. https://doi.org/10.1371/journal.pone.0027953